Abstract: The invention provides stable aqueous pharmaceutical formulations comprising an anti-PDL1 antibody. The invention also provides methods for making such formulations and methods of using such formulations.

Abstract: The present technique pertains to an image capturing apparatus and a signal processing method that enable power consumption to be lowered for a sensor equipped with a DNN (Deep Neural Network). The image capturing apparatus performs a DNN (Deep Neural Network) process on image data that is generated by image capturing, outputs a trigger signal for controlling stopping or driving of the DNN process, and, on the basis of the trigger signal, controls stopping of the DNN process or driving of the DNN process and output to a subsequent stage. The present technique can be applied to an image capturing apparatus that is provided with an image sensor which is equipped with a DNN.

Abstract: A pulmonary function identifying and treating method includes: obtaining a first image, having first image elements, and a second image, having second image elements, respectively corresponding to a first state and a second state of a lung; extracting first feature points of the first image and second feature points of the second image; registering the first image with the second image using a boundary point set registration method and an inner tissue registration method according to the first feature points and the second feature points, so that the first image elements correspond to the second image elements and tissue units of the lung; determining functional index values representative of the tissue units of the lung using a ventilation function quantification method according to the first image elements and the second image elements corresponding to the first image elements; and treating the lung according to the functional index values.

Abstract: Membranes are provided. A membrane comprises a cap layer, a core layer, and a substrate located between the cap layer and the core layer. The cap layer comprises a first cap sublayer and a second cap sublayer, with the second cap sublayer located between the first cap sublayer and the substrate. The first cap sublayer comprises a first thermoplastic polymer, and no greater than 10 parts of a first fire retardant per 100 parts of the first thermoplastic polymer. The second cap sublayer comprises a second thermoplastic polymer, and a second fire retardant, wherein an amount of the second fire retardant in the second cap sublayer is greater than an amount of the first fire retardant in the first cap sublayer. Related systems and methods are also provided.

Abstract: The present invention discloses a constant temperature nucleic acid amplification RAA primer probe combination for detecting Candida auris and use thereof are provided. The primer probe combination has high amplification efficiency, strong specificity, and no obvious false positive, and can effectively distinguish Candida auris from three closely related bacteria frequently misdiagnosed in a clinical microorganism identification system. Based on an RAA-lateral flow chromatography technology, the present invention establishes a method for rapidly detecting Candida auris can be used for detecting an actual sample after passing the specificity and sensitivity evaluation, and provides a rapid, sensitive, reliable, and effective new method for on-site rapid detection of Candida auris. The method does not need complex instruments, and is particularly suitable for rapid screening and detection of Candida auris in basic laboratories and quarantine sites.

Abstract: Some embodiments of the present disclosure relate to a roofing system. In some embodiments, the roofing system includes a roofing membrane, which may include a cap, a scrim, and a core. In some embodiments, the roofing system may also include an adhesive film, which may include a first adhesive layer adhered to the roofing membrane, a second adhesive layer configured to adhere the roofing membrane to a roofing substrate, and a barrier layer positioned between the first and second adhesive layers. Methods of manufacturing roofing systems are also disclosed.

Abstract: A metastable, translucent flavor nanoemulsion is provided. The nanoemulsion contains a flavor oil phase, an aqueous phase, and a surfactant system containing a first lecithin and a second lecithin. The nanoemulsion is free of any non-natural surfactant. The surfactant system contains free fatty acid 15% or less. The first lecithin has an HLB of 1 to 8, and the second lecithin has an HLB of 8 to 16 and contains phosphatidylcholine and lysophosphatidylcholine 20% or greater. Also disclosed are a method for preparing the nanoemulsion and use of the nanoemulsion in liquid beverages and liquid beverage concentrates.

Abstract: This disclosure provides a fluorine-containing mixture and a fluorine-containing super-oleophobic microporous membrane using the fluorine-containing mixture as a raw material, as well as preparation methods and applications for the fluorine-containing mixture and the fluorine-containing super-oleophobic microporous membrane. The fluorine-containing mixture of the present disclosure comprises, by weight percentage, the following components: Component A: 50%˜90%; Component B: 3%˜25%; Component C: 0%˜35%; Component D: 0%˜3%; wherein Component A comprises high molecular weight polytetrafluoroethylene homopolymer or copolymer dispersion resin; Component B comprises one or more fluorine-containing alkyl acrylate monomers; Component C comprises one or more fluorine-free acrylates; Component D comprises high temperature free radical initiator.

Abstract: Disclosed herein are embodiments of an Al—Ce—Cu alloy for use in additive manufacturing. The disclosed alloy embodiments provide fabricated objects, such as bulk components, comprising a heterogeneous microstructure and having good mechanical properties even when exposed to conditions used during the additive manufacturing process. Methods for making and using alloy embodiments also are disclosed herein.

Abstract: A synchronous driving device includes a driving source and a driving drive mechanism. The driving drive mechanism includes a first housing and a driving transmission assembly arranged in the first housing and engaged in transmission. The driving transmission assembly includes an input shaft, a first output shaft, a second output shaft and a third output shaft. A driving end of the driving source is connected with the input shaft. The third output shaft is perpendicular to the first output shaft and the second output shaft. The first output shaft, the second output shaft and the third output shaft are configured to be driven by the driving source to rotate synchronously. A photovoltaic tracking bracket system having the synchronous driving device is also disclosed.

Abstract: A method for testing a heat transfer fluid based on a charged wire test (CWT) includes applying and measuring discharge current through a test circuit formed when a cathode and an anode are at least partially immersed in the heat transfer fluid in a container and a voltmeter coupled to the cathode and the anode is turned on during the CWT. The method includes measuring temperature of the heat transfer fluid during the CWT, determining a current profile based on the measured discharge current, and determining a temperature profile based on the measured temperature. The method includes determining a pass/fail status and/or a rank status of the heat transfer fluid based on pass/fail criteria based on the current profile and the temperature profile during an entire duration of the CWT.

Abstract: A compound and the method for treating bacterial infections thereof are provided, wherein the compound is derived from AS101 and having a general formula (I) or a general formula (II), and wherein the method includes administering an effective amount of compound having the general formula (I) or a compound having the general formula (I) and its pharmaceutically acceptable salt thereof.

Abstract: One aspect of the present application relates to a recombinant cell comprising a chimeric antigen receptor and shRNA targeted to inhibit the life cycle of HIV. Another aspect of the present application relates to a chimeric antigen molecule, the extracellular region of which is from or comprising the extracellular region of human CD4 molecule, the transmembrane region of which is from or comprising the transmembrane domain of CD8?, and a recombinant cell comprising the above chimeric antigen molecule. The above recombinant cell can be used to treat HIV infection, and have stronger comprehensive killing efficacy, longer effective time, and less risk of causing cytokine storm in the environment of HIV infection.

Abstract: Some embodiments of the present disclosure relate to a roofing system. In some embodiments, the roofing system includes a first roofing material, wherein the first roofing material comprises a top surface and a bottom surface. In some embodiments, the top surface of the first roofing material comprises a nail zone with a plurality of fines. In some embodiments, the roofing system includes a second roofing material, wherein the second roofing material comprises a top surface and a bottom surface. In some embodiments, the bottom surface of the second roofing material comprises a plurality of fines. In some embodiments, the roofing system comprises and a patterned adhesive, which directly contacts at least a portion of the plurality of fines in the nail zone and at least a portion of the plurality of fines on the bottom surface of the second roofing material.

Abstract: Oral care compositions and methods for treating, preventing, or inhibiting dry mouth and/or inflammation of the oral cavity or a surface thereof are disclosed. Oral care compositions for improving oral care by treating, preventing, or otherwise inhibiting discomfort, irritation, or gum pain of the oral cavity are also disclosed. The oral care composition may include an orally acceptable vehicle, hyaluronic acid, and one or more benefit agents. The method for treating, preventing, or inhibiting dry mouth and/or inflammation of the oral cavity or a surface thereof may include contacting the oral cavity or the surface thereof with the oral care compositions.

Abstract: Some embodiments relate to a roofing membrane. The roofing membrane comprises a scrim. The scrim has a top surface and a bottom surface. The roofing membrane comprises a cap layer on the top surface of the scrim. The cap layer comprises a first non-styrenic polypropylene polymer, a first polypropylene impact copolymer, and a first olefin block copolymer. The roofing membrane comprises a core layer on the bottom surface of the scrim. The core layer comprises a second non-styrenic polypropylene polymer, a second polypropylene impact copolymer, and a second olefin block copolymer. The roofing membrane is configured to prevent migration of at least one oil from a layer to the roofing membrane. Some embodiments relate to a roofing structure comprising the roofing membrane, a method for installing the roofing membrane, and the like.

Abstract: A photovoltaic support spindle, including at least a long shaft, where the long shaft includes a first flat panel, a second flat panel, a third flat panel, a first arc panel, a second arc panel, and a third arc panel; the first arc panel is connected between the second flat panel and the third flat panel; the second arc panel is connected between the first flat panel and the second flat panel; and the third arc panel is connected between the first flat panel and the third flat panel. The first arc panel, the second arc panel and the third arc panel are three arc surfaces distributed on a same cylindrical surface. The disclosure saves a material, reduces a cost and improves a bending resistance.

Abstract: An oral biology model which comprises biofilm, oral epithelial tissue and a suspension of neutrophil-like cells in media is disclosed. The biofilm, which comprises oral bacteria, is produced by culturing oral bacteria on a solid substrate. The oral epithelial tissue may be gingival epithelial tissue to model the gingival crevice or buccal epithelial tissue to model the oral check. The suspension of neutrophil-like cells in media comprises neutrophil-like cells that are differentiated HL60 cells induced to a neutrophil-like phenotype by treatment with retinoic acid. Methods of using the oral biology model to test and compare compounds and formulations or to screen compounds and formulations for their effect on release of inflammatory signals, their effect on biofilm and oral bacteria and/or their effect on the cellular components are disclosed.

Abstract: Some embodiments of the present disclosure relate to a roofing system. In some embodiments, the roofing system includes a roofing membrane, which may include a cap, a scrim, and a core. In some embodiments, the roofing system may also include an adhesive film, which may include a first adhesive layer adhered to the roofing membrane, a second adhesive layer configured to adhere the roofing membrane to a roofing substrate, and a barrier layer positioned between the first and second adhesive layers. Methods of manufacturing roofing systems are also disclosed.

Abstract: A synchronous driving device includes a driving source and a driving drive mechanism. The driving drive mechanism includes a first housing and a driving transmission assembly arranged in the first housing and engaged in transmission. The driving transmission assembly includes an input shaft, a first output shaft, a second output shaft, a third output shaft and a fourth output shaft. A driving end of the driving source is connected with the input shaft. Both the third output shaft and the fourth output shaft are perpendicular to the first output shaft and the second output shaft. The first output shaft, the second output shaft, the third output shaft and the fourth output shaft are configured to be driven by the driving source to rotate synchronously. A photovoltaic tracking bracket system having the synchronous driving device is also disclosed.